Sarah Waliany
- Oncology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Infectious Diseases top 10%
- Co-authors
- Ronald WittelesHan ZhuSean M. WuJoel W. NealPatricia K. NguyenMark M. DavisHolden T. MaeckerSandy Srinivas
- Topics
- Lung Cancer Treatments and Mutations (9 papers)Lung Cancer Research Studies (8 papers)Cancer Immunotherapy and Biomarkers (5 papers)
- Partner nations
- United StatesIndiaFrance
In The Last Decade
Sarah Waliany
33 papers receiving 838 citations
Peers
Comparison fields: 5 of 92
- Oncology 445
- Cardiology and Cardiovascular Medicine 209
- Pulmonary and Respiratory Medicine 177
- Molecular Biology 169
- Infectious Diseases 122
Countries citing papers authored by Sarah Waliany
This map shows the geographic impact of Sarah Waliany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Waliany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Waliany more than expected).
Fields of papers citing papers by Sarah Waliany
This network shows the impact of papers produced by Sarah Waliany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Waliany. The network helps show where Sarah Waliany may publish in the future.
Co-authorship network of co-authors of Sarah Waliany
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Waliany. A scholar is included among the top collaborators of Sarah Waliany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Waliany. Sarah Waliany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 9 | |
| 9 | 14 | |
| 10 | 103 | |
| 11 | 7 | |
| 12 | 4 | |
| 13 | 21 | |
| 14 | 77 | |
| 15 | 59 | |
| 16 | 44 | |
| 17 | 17 | |
| 18 | 5 | |
| 19 | 53 | |
| 20 | 39 |
About Sarah Waliany
Sarah Waliany is a scholar working on Oncology, Family Practice and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 857 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (8 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Oncology (445 citations), Cardiology and Cardiovascular Medicine (209 citations) and Infectious Diseases (122 citations). Sarah Waliany has collaborated with scholars based in United States, India and France. Frequent co-authors include Ronald Witteles, Han Zhu, Sean M. Wu, Joel W. Neal, Patricia K. Nguyen, Mark M. Davis, Holden T. Maecker, Sandy Srinivas, Joanne Mortimer and Heather A. Wakelee. Their work appears in journals such as Circulation, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.